Cdk inhibitors in development and cancer

Current Opinion in Genetics and Development

Volumn 6, Issue 1, 1996, Pages 56-64

  Harper, J Wade ^a   Elledge, Stephen J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; PROTEIN P21; PROTEIN P53;

AMINO ACID SEQUENCE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; DEVELOPMENT; DNA DAMAGE; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; PRIORITY JOURNAL; REVIEW;

EID: 0030044817     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)90011-8     Document Type: Article

References (4)

1. 1 phase progression: cycling on cue. Cell 1994, 79:551-555.
2. Hunter T, Pines, J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
3. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828.
4. Peter M, Herskowitz I: Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994, 79:181-184.